These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6318344)

  • 21. Pharmacokinetics and relative bioavailability after single dose administration of 25 mg ketoprofen solution as compared to tablets.
    Stiegler S; Birkel M; Jost V; Lange R; Lücker PW; Wetzelsberger N
    Methods Find Exp Clin Pharmacol; 1995 Mar; 17(2):129-34. PubMed ID: 7674700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of ketoprofen following single oral, intramuscular and rectal doses and after repeated oral administration.
    Ishizaki T; Sasaki T; Suganuma T; Horai Y; Chiba K; Watanabe M; Asuke W; Hoshi H
    Eur J Clin Pharmacol; 1980 Nov; 18(5):407-14. PubMed ID: 7439263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of combination treatment with ketoprofen 100 mg + acetaminophen 1000 mg on postoperative dental pain: a single-dose, 10-hour, randomized, double-blind, active- and placebo-controlled clinical trial.
    Akural EI; Järvimäki V; Länsineva A; Niinimaa A; Alahuhta S
    Clin Ther; 2009 Mar; 31(3):560-8. PubMed ID: 19393845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human pharmacokinetics of indoprofen.
    Tamassia V
    Eur J Rheumatol Inflamm; 1981; 4(1):11-5. PubMed ID: 7341274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of metoclopramide and atropine on the absorption of orally administered mexiletine.
    Wing LM; Meffin PJ; Grygiel JJ; Smith KJ; Birkett DJ
    Br J Clin Pharmacol; 1980 May; 9(5):505-9. PubMed ID: 6994791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Impact of the method and timing of administration on the systemic transport of ketoprofen].
    Delhotal Landes B; Decout N; Molinier P; Flouvat B
    Pathol Biol (Paris); 1998 May; 46(5):355-9. PubMed ID: 9769898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic profile of controlled release ketoprofen in elderly patients.
    Dennis MJ; French PC; Crome P; Babiker M; Shillingford J; Hopkins R
    Br J Clin Pharmacol; 1985 Dec; 20(6):567-73. PubMed ID: 4091989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic and therapeutic effects of ketoprofen.
    Sala G; Silvestri N; Castegnaro E; Pollini C
    Farmaco Prat; 1978 Oct; 33(10):455-60. PubMed ID: 312213
    [No Abstract]   [Full Text] [Related]  

  • 29. Intravenous pharmacokinetics, oral bioavailability and dose proportionality of ragaglitazar, a novel PPAR-dual activator in rats.
    Jagannath K; Chaluvadi MR; Mullangi R; Mamidi NV; Srinivas NR
    Biopharm Drug Dispos; 2004 Oct; 25(7):323-8. PubMed ID: 15386480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacokinetics of ketoprofen in patients with renal failure].
    Stafanger G; Larsen HW; Hansen H; Serensen K
    Sem Hop; 1983 Dec; 59(46):3191-3. PubMed ID: 6318338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suprofen kinetics in healthy male volunteers after intramuscular injection of increasing dosages.
    Zulliger HW; Fassolt A
    Arzneimittelforschung; 1983; 33(9):1322-6. PubMed ID: 6685517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of ketoprofen in the elderly.
    Advenier C; Roux A; Gobert C; Massias P; Varoquaux O; Flouvat B
    Br J Clin Pharmacol; 1983 Jul; 16(1):65-70. PubMed ID: 6882624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ketoprofen pharmacokinetics and bioavailability based on an improved sensitive and specific assay.
    Upton RA; Williams RL; Guentert TW; Buskin JN; Riegelman S
    Eur J Clin Pharmacol; 1981; 20(2):127-33. PubMed ID: 7262174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of ketoprofen in patients with chronic renal failure.
    Stafanger G; Larsen HW; Hansen H; Sørensen
    Scand J Rheumatol; 1981; 10(3):189-92. PubMed ID: 7291952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aluminum bioavailability from the approved food additive leavening agent acidic sodium aluminum phosphate, incorporated into a baked good, is lower than from water.
    Yokel RA; Florence RL
    Toxicology; 2006 Oct; 227(1-2):86-93. PubMed ID: 16949191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and metabolism of tesaglitazar, a novel dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist, after a single oral and intravenous dose in humans.
    Ericsson H; Hamrén B; Bergstrand S; Elebring M; Fryklund L; Heijer M; Ohman KP
    Drug Metab Dispos; 2004 Sep; 32(9):923-9. PubMed ID: 15319332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative pharmacokinetics of ketoprofen derived from single oral doses of ketoprofen capsules or a novel sustained-release pellet formulation.
    Houghton GW; Dennis MJ; Rigler ED; Parsons RL
    Biopharm Drug Dispos; 1984; 5(3):203-9. PubMed ID: 6487749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical pharmacokinetics of ketoprofen after single intravenous administration as a bolus or infusion.
    Debruyne D; Hurault de Ligny B; Ryckelynck JP; Albessard F; Moulin M
    Clin Pharmacokinet; 1987 Mar; 12(3):214-21. PubMed ID: 3581635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Double-blind comparative study of Bi-Profenid tablets and Profenid capsules in inflammatory rheumatism].
    Camus JP; Fournie A; Ayrolles C; Koeger AC; Prier A
    Sem Hop; 1983 Dec; 59(46):3221-4. PubMed ID: 6318346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absolute bioavailability of paracetamol after oral or rectal administration in healthy volunteers.
    Eandi M; Viano I; Ricci Gamalero S
    Arzneimittelforschung; 1984; 34(8):903-7. PubMed ID: 6548636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.